In a report released today, Adam Maeder from Piper Sandler reiterated a Hold rating on Vicarious Surgical (RBOT – Research Report), with a price target of $4.00. The company’s shares closed yesterday at $2.11.
Maeder covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Nevro Crop, and LivaNova. According to TipRanks, Maeder has an average return of 19.2% and a 56.88% success rate on recommended stocks.
Currently, the analyst consensus on Vicarious Surgical is a Moderate Buy with an average price target of $5.50.
See Insiders’ Hot Stocks on TipRanks >>
RBOT market cap is currently $272.1M and has a P/E ratio of 75.36.
Based on the recent corporate insider activity of 126 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of RBOT in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
D8 Holdings Corp is a blank check company.
Read More on RBOT:
